Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

By afschroeder • August 12, 2025

Sitbon O, Sahay S, Escribano Subías P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiéry JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS; TORREY Study Investigators. Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study. Adv Ther. 2025 Aug 11. doi: 10.1007/s12325-025-03297-2. Epub ahead of print. PMID: 40788460.

Tags: efficacy, Inhaled tyrosine kinase inhibitor, long-term, PDGFR inhibitor, Publications, pulmonary arterial hypertension, pulmonary vascular resistance, Pulmonary, Critical Care & Sleep Medicine, safety, Seralutinib

Prolonged and Recurrent De Quervain’s Thyroiditis After Thyroid Fine Needle Aspiration

Lane K, Pelikh B, Rao J, Cheung DS. Prolonged and Recurrent De Quervain's Thyroiditis After Thyroid Fine Needle Aspiration. Cureus. 2025 Jul 12;17(7):e87767. doi: 10.7759/cureus.87767.[...]

Evaluating Whole Health Engagement Among Homeless-Experienced Veterans in an Emergency Shelter: A Quality Improvement Study

Saleh T, Gelberg L, Chinchilla MY, Allen JE, Connor KL, Altman L, Capone-Newton P. Evaluating Whole Health Engagement Among Homeless-Experienced Veterans in an Emergency Shelter:[...]

Sex-based associations between neighborhood disadvantage and brain-gut alterations in individuals with irritable bowel syndrome

Kilpatrick LA, Chang L, Labus JS, Shin AS, Choy M, Dong TS, Naliboff B, Mayer EA, Church A. Sex-based associations between neighborhood disadvantage and brain-gut[...]